<DOC>
	<DOCNO>NCT01292824</DOCNO>
	<brief_summary>This phase I pilot study determine safety preliminary efficacy novel hepatitis C virus ( HCV ) entry inhibitor ( ITX 5061 ) patient HCV infection undergo liver transplantation .</brief_summary>
	<brief_title>Pilot Study Hepatitis C Virus Entry Inhibitor ( ITX 5061 ) Liver Transplant Recipients</brief_title>
	<detailed_description>Hepatitis C virus ( HCV ) infection common treatment option present limited . Recurrence HCV infection liver transplantation inevitable disease progression rapid compare disease non-transplanted liver . Studies ITX 5061 vitro show potent inhibitor HCV entry hepatocytes , block interaction virus scavenger receptor BI suggesting may reduce graft re-infection rate liver transplant . There study treatment block host receptor HCV investigator hypothesize ITX 5061 modulate HCV kinetics early phase post liver transplant .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Age ≥ 18 year old , ≤ 65 year old Plasma HCV RNA positive time list liver transplantation Accepted liver transplantation : Endstage liver disease due HCV infection Endstage liver disease due HCV infection alcohol relate liver disease ( ALD ) HCC due HCV Refusal inability give inform consent Viral coinfection either hepatitis B virus ( HBV ) human immunodeficiency virus ( HIV ) Pregnancy breastfeed Women , childbearing potential , willing practice effective contraception Men , sexually active woman childbearing potential , willing practice effective contraception Any situation Investigator 's opinion may interfere optimal study participation Participation clinical study investigational agent within 30 day recruitment Transplantation donor organ HCV positive individual</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Hepatitis C virus</keyword>
	<keyword>Entry</keyword>
	<keyword>Scavenger receptor-BI</keyword>
	<keyword>High density lipoprotein</keyword>
	<keyword>Liver transplantation</keyword>
</DOC>